PATENT CLAIM ANALYSIS

Application Number: 16056478
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "093700"]

Abstract:
The present invention is based in part methods for treating neurodegenerative diseases and disorders. Specifically, the present invention disclose methods for treating neurodegenerative disorders suing neural stem cells (NSCs) and/or pluripotent stem cell (PSC) derived neurons or neuron precursor cells. The present invention also discloses methods to induce endogenous dopaminergic neurons to release dopamine and increase the levels of dopamine in a subject.

Claim (Index 14):
The method of  claim 1 , wherein the NSCs, neuron precursor cells or neurons or the PSCs are human.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.47917
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14181285', '14396180', '15726121', '14356042', '15016934']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7236441934408736
- 35 USC 102 Novelty (BERT): 0.6207335033675293
- Combined Prediction Score: 0.7133531244335392
- Mean Citation Score: 450.77079
- Max Citation Score: 661.95154
- Similarity Product: 470.5105331121159

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test